Pharmaceutical company Bayer AG is buying Steigerwald Arzneimittelwerk GmbH for an undisclosed amount.

Steigerwald, headquartered in Darmstadt, Germany, makes herbal medicines, including Iberogast, which is used to treat gastrointestinal disorder, and Laif, which aims to treat depression.

The deal allows Leverkusen, Germany-based Bayer to increase its product offerings for gastrointestinal disorders. 

In September, the company bought Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) animal health business for $145 million. 

In April, Bayer sold Baynik, a nano-silver ink technology company, to Clariant International AG. 

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.